Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Infect Dis ; 20(1): 260, 2020 Apr 03.
Artigo em Inglês | MEDLINE | ID: mdl-32245368

RESUMO

BACKGROUND: Infection by hepatitis E virus (HEV) can cause a high burden of morbidity and mortality in countries with poor access to clean water and sanitation. Our study aimed to investigate the situation of HEV infections in the Central African Republic (CAR). METHODS: A retrospective analysis of the blood samples and notification forms collected through the national yellow fever (YF) surveillance program, but for which a diagnosis of YF was discarded, was carried out using an anti-HEV IgM ELISA and a HEV-specific RT-PCR. RESULTS: Of 2883 YF-negative samples collected between January 2008 and December 2012, 745 (~ 26%) tested positive by at least either of the 2 tests used to confirm HEV cases. The results revealed that the CAR was hit by a large HEV outbreak in 2008 and 2009. The results also showed a clear seasonal pattern with correlation between HEV incidence and rainfall in Bangui. A phylogenetic analysis showed that the circulating strains belonged to genotypes 1e and 2b. CONCLUSIONS: Overall, this study provides further evidences that HEV can be a significant cause of acute febrile jaundice, particularly among adults during rainy season or flood, in a country from Sub-Saharan Africa.


Assuntos
Surtos de Doenças , Vírus da Hepatite E/genética , Vírus da Hepatite E/imunologia , Hepatite E/diagnóstico , Hepatite E/epidemiologia , Chuva , Doenças Transmitidas pela Água/epidemiologia , Adolescente , Adulto , República Centro-Africana/epidemiologia , Criança , Ensaio de Imunoadsorção Enzimática , Feminino , Inundações , Genótipo , Anticorpos Anti-Hepatite/sangue , Hepatite E/complicações , Hepatite E/virologia , Vírus da Hepatite E/isolamento & purificação , Humanos , Imunoglobulina M/sangue , Incidência , Icterícia/etiologia , Estudos Longitudinais , Masculino , Filogenia , Reação em Cadeia da Polimerase em Tempo Real , Estudos Retrospectivos , Doenças Transmitidas pela Água/virologia , Adulto Jovem
2.
BMC Infect Dis ; 13: 286, 2013 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-23800310

RESUMO

BACKGROUND: As most data on hepatitis in resource-poor countries relate to urban communities, surveys in the rural environment are necessary to determine the 'true' prevalence of these viral infections. We undertook a survey to determine the prevalence of hepatitis B virus (HBV) infection in an apparently healthy rural population in the Central African Republic (CAR). METHODS: The cross-sectional study was based on dried blood spots (DBS) from 273 people recruited in four prefectures (Lobaye, Nana-Mambéré, Ouham and Ouaka). Eluates from DBS were tested with commercial ELISA kits to detect markers of HBV infection. DBS were directly used for DNA extraction, followed by PCR and genotyping based on preS/S gene sequences. RESULTS: The overall prevalence of HBc antibodies was 27.1% (Lobaye 29%, Nana-Mambéré 28%, Ouaka 29% and Ouham 23%) and that of HBsAg was 10.6% (Lobaye 9%, Nana-Mambéré 9%, Ouaka 19% and Ouham 8%), with no statistically significant difference among the surveyed communities. Nineteen sequences obtained from 74 anti-HBc-positive patients all belonged to genotype E. Risk factor analysis of HBV infection pointed to sexual transmission of the virus. CONCLUSION: The prevalence of HBV is high in rural communities in the CAR and comparable to that observed in urban areas. In addition, genotype E is prevalent in these areas. These findings underline the importance of instituting a programme of active HBV surveillance and vaccination of the population.


Assuntos
Hepatite B/epidemiologia , Adolescente , Adulto , Idoso , República Centro-Africana/epidemiologia , Criança , Pré-Escolar , Estudos Transversais , Feminino , Técnicas de Genotipagem , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Filogenia , Prevalência , Fatores de Risco , População Rural/estatística & dados numéricos , Adulto Jovem
3.
BMC Infect Dis ; 10: 226, 2010 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-20670399

RESUMO

BACKGROUND: Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The global epidemiological scenario of HBV infection has been changing rapidly over the last two decades due to an effective immunization programme initiated by the World Health Organization. The objective of this study is to estimate the prevalence of HBV in apparently healthy young people and to identify the risk factors of transmission of the HBV among this population in Bangui. METHODS: Dried blood Spots from 801 adolescent high school and young adult university students were prepared by spotting a drop of whole blood (4 spots) from the same fingerprick onto Whatman filter paper. A blood sample aliquot eluted from DBS was then processed with commercial ELISA tests (Abbott Murex, Dartfort, UK) to detect HBsAg antigen, Anti-HBc and Anti-HBs antibodies). RESULTS: The overall prevalence was 42.3% for antibody to hepatitis B core antigen, 15.5% for HBsAg of which 1.3% of HBsAg alone. HBV familial antecedents, sexual activity and socioeconomic conditions were the main risk factors of HBV infection encountered in the adolescents and young adults. CONCLUSION: These results show for the first time the high prevalence of HBV in apparently healthy young people in Bangui. This high prevalence is age- and sex-independent. Transmission risk factors were a familial antecedent of HBV, no utilisation of condoms and public scholarship. To lower HBV prevalence, an adequate program of active screening and vaccination for adolescents and young adults should be implemented, along with a universal immunization program.


Assuntos
Portador Sadio/epidemiologia , Vírus da Hepatite B/isolamento & purificação , Hepatite B/epidemiologia , Estudantes , Adolescente , Adulto , Sangue/imunologia , Sangue/virologia , Portador Sadio/imunologia , Portador Sadio/virologia , República Centro-Africana/epidemiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Hepatite B/imunologia , Hepatite B/virologia , Anticorpos Anti-Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Instituições Acadêmicas , Estudos Soroepidemiológicos , Universidades , Adulto Jovem
4.
Clin Exp Med ; 18(3): 421-431, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29749584

RESUMO

Hepatocellular carcinoma (HCC) is still a major killing malignancy in sub-Saharan Africa. Lifelong intoxication with aflatoxin B1 is considered as one of the primary causes of this situation. The role of aflatoxin in HCC from a given population is commonly estimated through the prevalence of R249S mutation of TP53, a hallmark for previous exposure to the mycotoxin. However, the role of AFB1 is barely known in large part of Africa. We conducted a survey on circulating cell-free DNA from 149 patients with HCC and 213 control subjects with and without liver diseases from Cameroon and Central African Republic using droplet digital PCR technique. We observed a mutation prevalence of 24.8% (n = 37/149) in patients with tumor and 5.6% (n = 12/213) in controls (P = 2.2E-07). Patients with mutations usually displayed significantly increased circulating alpha-fetoprotein (AFP) values, high hepatitis B virus (HBV) DNA loads as well as worsened values of blood cells count. Interestingly, the fraction of droplets positive for R249S was significantly larger in patients with liver cancer (15.3 ± 3.7%) than in controls (0.5 ± 0.3%, P = 7.1E-04). Our survey indicates that AFB1 is instrumental for HCC development in Middle Africa and that droplet digital PCR might be used in the region both to diagnose HCC and to conduct public health surveys on populations at risk of chronic aflatoxin intoxication.


Assuntos
Carcinoma Hepatocelular/diagnóstico , Ácidos Nucleicos Livres/genética , Hepatite B Crônica/diagnóstico , Neoplasias Hepáticas/diagnóstico , Reação em Cadeia da Polimerase/métodos , Proteína Supressora de Tumor p53/genética , Adolescente , Adulto , Aflatoxina B1/toxicidade , Idoso , Idoso de 80 Anos ou mais , Camarões , Carcinoma Hepatocelular/induzido quimicamente , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/virologia , Estudos de Casos e Controles , Ácidos Nucleicos Livres/sangue , República Centro-Africana , DNA Viral/genética , Feminino , Expressão Gênica , Antígenos de Superfície da Hepatite B/sangue , Antígenos de Superfície da Hepatite B/genética , Vírus da Hepatite B/genética , Vírus da Hepatite B/isolamento & purificação , Hepatite B Crônica/genética , Hepatite B Crônica/patologia , Hepatite B Crônica/virologia , Humanos , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/virologia , Masculino , Pessoa de Meia-Idade , Taxa de Mutação , Proteína Supressora de Tumor p53/sangue , Carga Viral , alfa-Fetoproteínas/genética , alfa-Fetoproteínas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA